Neggram Related Published Studies
Well-designed clinical trials related to Neggram (Nalidixic Acid)
Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. [2007.03]
A comparative study of genotoxic effects in the treatment of trichomonas vaginalis infection: metronidazole or nalidixic acid. [2000.07]
A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. [2000.07]
Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid. [2000.05]
Effect of antimicrobial (nalidixic acid) therapy in shigellosis and predictive values of outcome variables in patients susceptible or resistant to it. [1995.04]
Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial. [1995.01]
Double-blind comparison of oral gentamicin and nalidixic acid in the treatment of acute shigellosis in children. [1994.12]
Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children. [1994.04]
Assessment of the effects of ciprofloxacin and nalidixic acid on cerebral blood flow and metabolism in healthy subjects by positron emission tomography. [1994.03]
Therapy for shigellosis. I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. [1988.11]
Failure of single-dose metronidazole prophylaxis in colorectal surgery. No benefit from high dosage or combination with nalidixic acid. [1988.04]
Well-designed clinical trials possibly related to Neggram (Nalidixic Acid)
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). [2011.10.05]
A multi-center randomized trial to assess the efficacy of gatifloxacin versus ciprofloxacin for the treatment of shigellosis in Vietnamese children. [2011.08]
The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. [2011.06]
Temporal fluctuation of multidrug resistant salmonella typhi haplotypes in the mekong river delta region of Vietnam. [2011.01.04]
Ciprofloxacin dosage and emergence of resistance in human commensal bacteria. [2009.08.01]
Effects of a siderophore receptor and porin proteins-based vaccination on fecal shedding of Escherichia coli O157:H7 in experimentally inoculated cattle. [2009.04]
Azithromycin for treating uncomplicated typhoid and paratyphoid fever (enteric fever). [2008.10.08]
Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). [2008.10.08]
Molting in Salmonella Enteritidis-Challenged Laying Hens Fed Alfalfa Crumbles. I. Salmonella Enteritidis Colonization and Virulence Gene hilA Response. [2007.08]
A randomized comparison of oral chloramphenicol versus ofloxacin in the treatment of uncomplicated typhoid fever in Laos. [2005.06]
Comparative trial of short-course ofloxacin for uncomplicated typhoid fever in Vietnamese children. [2005.03]
Double blind comparison of ibuprofen and paracetamol for adjunctive treatment of uncomplicated typhoid fever. [2004.03]
Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin. [1999.11]
In vitro susceptibility of new generation of antibacterial antibiotics against pathogenic bacteria. [1999.02]
Increased height gain of children fed a high-protein diet during convalescence from shigellosis: a six-month follow-Up study. [1998.10]
Evaluation of a selective transport medium for gastric biopsy specimens to be cultured for Helicobacter pylori. [1998.10]
[Prevention of reinfection by L-methionine in patients with recurrent urinary tract infection] [1997.10.15]
Short courses of ofloxacin for the treatment of enteric fever. [1997.05]
Urine bactericidal activity of pefloxacin versus norfloxacin in healthy female volunteers after a single 800-mg oral dose. [1997.03]
Double-blind, randomized clinical trial for safety and efficacy of norfloxacin for shigellosis in children. [1997.03]
Efficacy of antimicrobial treatment in non-dysenteric persistent diarrhoea in a community setting. [1996.11]
Application of direct-fed microbial bacteria and fructooligosaccharides for salmonella control in broilers during feed withdrawal. [1996.02]
Comparative trial of five antimicrobial compounds in the treatment of cholera in adults. [1995.01]
Enteric protein loss and intestinal permeability changes in children during acute shigellosis and after recovery: effect of zinc supplementation. [1994.12]
[Antibacterial activity of ciprofloxacin in the urine during four days after a single 500 mg and 750 mg oral dose] [1994.06]
Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora. [1994.04]
Clinical and laboratory studies of the photosensitizing potential of norfloxacin, a 4-quinolone broad-spectrum antibiotic. [1993.03]
Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial. [1992.09]
Randomized clinical trial of norfloxacin for shigellosis. [1991.12]
Oral zinc supplementation in persistent diarrhoea in infants. [1990.03]
Treatment of recurrent urinary tract infection with norfloxacin versus trimethoprim-sulfamethoxazole. [1990.02]
Effect of protein rich diet during acute phase of dysentery. [1990.01]
Effect of quinolone antimicrobials on theophylline pharmacokinetics. [1989.07]
Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. [1989.06.01]
Norfloxacin versus co-trimoxazole for treatment of urinary tract infections in adults: microbiological results of a coordinated multicentre study. [1987]
Other research related to Neggram (Nalidixic Acid)
Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis. [2008.01]
Efficient approach to acyloxymethyl esters of nalidixic acid and in vitro evaluation as intra-ocular prodrugs. [2006.04.15]
Synthesis and evaluation of new quinazolone derivatives of nalidixic acid as potential antibacterial and antifungal agents. [2006.02]
Treatment failure in a typhoid patient infected with nalidixic acid resistant S. enterica serovar Typhi with reduced susceptibility to ciprofloxacin: a case report from Cameroon. [2005.06.21]
Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. [2005.05.18]
Increasing incidence of resistance to nalidixic acid in shigellas from humans in England and Wales: implications for therapy. [2004.11]
Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease. [2004.09]
Studies on molecular interactions between nalidixic acid and liposomes. [2004.07.26]
Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease. [2004.07]
The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam. [2004.07]
Other possibly related research studies
In-vitro mutagenesis of qnrA and qnrS genes and quinolone resistance in Escherichia coli. [2007.09]
Prevalence and antimicrobial resistance of Campylobacter in US dairy cattle. [2007.06]
Prevalence and antibiotic resistance of Campylobacter spp. isolated from chicken meat, pork, and beef in Korea, from 2001 to 2006. [2007.04]
Evaluation of a survey approach to estimating the prevalence of cattle carrying antimicrobial-resistant Escherichia coli. [2007.04.18]
Antimicrobial resistance among enterobacteriaceae causing uncomplicated urinary tract infections in Mauritius: consequences of past misuse of antibiotics. [2007.04]
Clinical and microbiological investigations of typhoid fever in an infectious disease hospital in Kuwait. [2007.04]
Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea. [2007.03]
Typhoid fever: narrowing therapeutic options in India. [2006.11]
Transmission of Escherichia coli O157:H7 to cattle by house flies. [2007.06.15]
Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility. [2007.04]
Primary gluteal abscess due to Salmonella typhimurium: a case report and review of the literature. [2007.02]
Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin. [2007.02]
Prevalence of antimicrobial resistance among Salmonella on midwest and northeast USA dairy farms. [2007.05.16]
Diclofenac in the management of E. coli urinary tract infections. [2006.09]
Cefotaxime-ciprofloxacin combination therapy for nontyphoid Salmonella bacteremia and paravertebral abscess after failure of monotherapy. [2006.11]
Antimicrobial resistance in non-typhoidal salmonellas from humans in Northern Ireland, 2001-2003: standardization needed for better epidemiological monitoring. [2007.05]
Antimicrobial resistance profiling and fla-typing of Irish thermophillic Campylobacter spp. of human and poultry origin. [2006.11]
[Comparative susceptibility evolution in Escherichia coli from urinary tract infections in outpatients and inpatients at Perpignan hospital in 2002 and 2004] [2006.10]
Shedding of escherichia coli O157:H7 by cattle fed diets containing monensin or tylosin. [2006.09]
Photosensitized DNA damage and its protection via a novel mechanism. [2007.01]
The effect of feed deprivation on tissue invasion by Salmonella enteritidis. [2006.08]
Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2. [2006.08]
Age-related clinical and microbiological characteristics of enteric fever in India. [2006.10]
Antimicrobial resistance in non-typhoidal Salmonella from human sources, Spain, 2001-2003. [2006.08]
Multidrug-resistant commensal Escherichia coli in children, Peru and Bolivia. [2006.06]
Prevalence of Clostridium difficile in the environment in a rural community in Zimbabwe. [2006.12]
Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A. [2006.04]
Multilaboratory evaluation of disk diffusion antimicrobial susceptibility testing of Neisseria meningitidis isolates. [2006.05]
Effects of chronic triclosan exposure upon the antimicrobial susceptibility of 40 ex-situ environmental and human isolates. [2006.05]
Low-level fluoroquinolone resistance among Campylobacter jejuni isolates in Australia. [2006.05.15]
Sensitivities of antigen detection and PCR assays greatly increased compared to that of the standard culture method for screening for group B streptococcus carriage in pregnant women. [2006.03]
Molecular characterisation of bovine faecal Escherichia coli shows persistence of defined ampicillin resistant strains and the presence of class 1 integrons on an organic beef farm. [2006.06.15]
Multidrug resistance and distribution of Salmonella serovars in slaughtered pigs. [2006.02]
Antimicrobial resistance in E.coli associated with urinary tract infection in the west of Ireland. [2005.10]
Outbreak of Shigella sonnei gastroenteritis in Northeastern Taiwan. [2006.01]
Is Campylobacter involved in antibiotic associated diarrhoea? [2005.10]
Nontyphoidal Salmonella from human clinical cases, asymptomatic children, and raw retail meats in Yucatan, Mexico. [2006.01.01]
Epidemiology of typhoid fever in Mauritius. [2005.09]
Increasing incidence of quinolone resistance in human non-typhoid Salmonella enterica isolates in Korea and mechanisms involved in quinolone resistance. [2005.12]
Effect of quinolone treatment on selection and persistence of quinolone-resistant Escherichia coli in swine faecal flora. [2005]
Current perspectives of enteric fever: a hospital-based study from India. [2005.09]
Effect of pooling bovine fecal samples on the sensitivity of detection of E. coli O157:H7. [2005.09.30]
Frequency and treatment of urinary tract infection in children subjected to urine culture, in Sana'a, Yemen. [2005.04]
Insertional mutation of marA vitiates inducible multiple antimicrobial resistance in Salmonella enterica subsp. enterica serovar Choleraesuis. [2005.08.30]
Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo. [2005.05]
|